UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

74 GENETICS OF ADHD DIMENSIONS: BIOLOGICAL AND CLINICAL IMPLICATIONS FOR ADHD

European neuropsychopharmacology, 2019-10, Vol.29, p.S101-S101

Zayats, Tetyana

2019

Volltextzugriff (PDF)

The (Broad-Sense) Genetic Correlations Among Four Measures of Inattention and Hyperactivity in 12 Year Olds

Behavior genetics, 2020-07, Vol.50 (4), p.273-288

2020

Volltextzugriff (PDF)

GENETICS OF ADHD AND ITS UTILITY IN SCIENCE AND CLINIC

European neuropsychopharmacology, 2023-10, Vol.75, p.S20-S21

2023

Volltextzugriff (PDF)

W50. ADHD BEYOND DIAGNOSIS: INSIGHTS FROM GENETICS OF ADHD DOMAINS IN A WELL-CHARACTERIZED YOUTH CLINICAL SAMPLE

European neuropsychopharmacology, 2023-10, Vol.75, p.S130-S130

2023

Volltextzugriff (PDF)

5.23 Leveraging the Genetics of ADHD Symptom Dimensions in Child Psychiatric Outpatients

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-10, Vol.62 (10), p.S266-S266

2023

Volltextzugriff (PDF)

87. EXPLORATION OF BRAIN-HERITABLE METHYLATION IN SCHIZOPHRENIA CASES AND CONTROLS

European neuropsychopharmacology, 2022-10, Vol.63, p.e92

2022

Volltextzugriff (PDF)

A DNA METHYLATION STUDY OF THE ANTIPSYCHOTIC QUETIAPINE (SEROQUEL): TREATMENT EFFECTS IN SCHIZOPHRENIA AND BIPOLAR DISORDER

European neuropsychopharmacology, 2022-10, Vol.63, p.e131-e132

2022

Volltextzugriff (PDF)

0218 Sleep and Circadian Polygenic Risk Scores Predict Actigraphy-derived Traits and Cognition in Older Adults

Sleep (New York, N.Y.), 2024-04, Vol.47 (Supplement_1), p.A94-A94

2024

Volltextzugriff (PDF)

44. META-ANALYSIS OF GENOME-WIDE DNA METHYLATION IN SCHIZOPHRENIA: DOES SEX STRATIFICATION IMPROVE DISCOVERY?

European neuropsychopharmacology, 2023-10, Vol.75, p.S79-S80

2023

Volltextzugriff (PDF)

F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS

European neuropsychopharmacology, 2023-10, Vol.75, p.S262-S263

2023

Volltextzugriff (PDF)

GENETICALLY INFORMED EARLY IDENTIFICATION OF ATTENTION DEFICIT HYPERACTIVITY DISORDER SYMPTOMS IN THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT STUDY (MOBA)

European neuropsychopharmacology, 2023-10, Vol.75, p.S22-S23

2023

Volltextzugriff (PDF)

TH39. DOES TIME-OF-BLOOD DRAW IMPACT CELL-DERIVED DATA IN STUDIES OF SCHIZOPHRENIA?

European neuropsychopharmacology, 2021-10, Vol.51, p.e215-e216

2021

Volltextzugriff (PDF)

29. EPIGENOME-WIDE ASSOCIATION META-ANALYSIS OF ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

European neuropsychopharmacology, 2022-10, Vol.63, p.e61

2022

Volltextzugriff (PDF)

SU5A RARE VARIANT ANALYSIS ON ATTENTION-DEFICIT HYPERACTIVITY DISORDER

European neuropsychopharmacology, 2019, Vol.29, p.S1270-S1271

2019

Volltextzugriff (PDF)

INSIGHTS FROM >80 LOCI ASSOCIATED WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

European neuropsychopharmacology, 2023-10, Vol.75, p.S21-S21

2023

Volltextzugriff (PDF)

6.71 ATTENTION IS PREDICTED BY ALZHEIMER’S DISEASE POLYGENIC RISK SCORE IN TYPICALLY DEVELOPING CHILDREN MORE THAN IN CHILDREN WITH ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2019-10, Vol.58 (10), p.S294-S294

2019

Volltextzugriff (PDF)

PARENT-OF-ORIGIN EFFECTS IN CHILDHOOD AGGRESSION

European neuropsychopharmacology, 2022-10, Vol.63, p.e281

2022

Volltextzugriff (PDF)

76 GENETIC ARCHITECTURE OF PERSISTENT ATTENTION DEFICIT/HYPERACTIVITY DISORDER

European neuropsychopharmacology, 2019-10, Vol.29, p.S102-S103

2019

Volltextzugriff (PDF)

M2 THE ROLE OF LOW FREQUENCY VARIANTS ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND AUTISM SPECTRUM DISORDERS

European neuropsychopharmacology, 2019-10, Vol.29, p.S167-S167

2019

Volltextzugriff (PDF)

W6. IMPACTS OF GENETICS AND PRENATAL DIET QUALITY ON ADHD SYMPTOMS ACROSS CHILDHOOD - A LONGITUDINAL STUDY IN THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT

European neuropsychopharmacology, 2021-10, Vol.51, p.e149-e150

2021

Volltextzugriff (PDF)

Investigation of Shared Genetic Risk Between ADHD and Cardiometabolic Traits in a Norwegian Family Cohort Using Polygenic Transmission Disequilibrium Test

Biological psychiatry (1969), 2020-05, Vol.87 (9), p.S300

2020

Volltextzugriff (PDF)

A CONTRIBUTION OF RARE COPY NUMBER VARIATIONS TO THE DEVELOPMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER: GENOME-WIDE META-ANALYSES IN 12548 INDIVIDUALS

European neuropsychopharmacology, 2019, Vol.29, p.S1042-S1042

2019

Volltextzugriff (PDF)

F6GENETICS OF TREATMENT RESPONSE FOR ATOMOXETINE IN ADHD

European neuropsychopharmacology, 2019, Vol.29, p.S1113-S1113

2019

Volltextzugriff (PDF)

SU6HYPERACTIVITY SYMPTOM IS PREDICTED BY AGE-OF-MENARCHE POLYGENIC RISK SCORE IN ADHD CHILDREN

European neuropsychopharmacology, 2019, Vol.29, p.S1271-S1271

2019

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Zeitschrift / SerieMolecular Psychiatry

ThemaGenetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(46)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

74 GENETICS OF ADHD DIMENSIONS: BIOLOGICAL AND CLINICAL IMPLICATIONS FOR ADHD

The (Broad-Sense) Genetic Correlations Among Four Measures of Inattention and Hyperactivity in 12 Year Olds

GENETICS OF ADHD AND ITS UTILITY IN SCIENCE AND CLINIC

W50. ADHD BEYOND DIAGNOSIS: INSIGHTS FROM GENETICS OF ADHD DOMAINS IN A WELL-CHARACTERIZED YOUTH CLINICAL SAMPLE

5.23 Leveraging the Genetics of ADHD Symptom Dimensions in Child Psychiatric Outpatients

87. EXPLORATION OF BRAIN-HERITABLE METHYLATION IN SCHIZOPHRENIA CASES AND CONTROLS

A DNA METHYLATION STUDY OF THE ANTIPSYCHOTIC QUETIAPINE (SEROQUEL): TREATMENT EFFECTS IN SCHIZOPHRENIA AND BIPOLAR DISORDER

0218 Sleep and Circadian Polygenic Risk Scores Predict Actigraphy-derived Traits and Cognition in Older Adults

44. META-ANALYSIS OF GENOME-WIDE DNA METHYLATION IN SCHIZOPHRENIA: DOES SEX STRATIFICATION IMPROVE DISCOVERY?

F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS

GENETICALLY INFORMED EARLY IDENTIFICATION OF ATTENTION DEFICIT HYPERACTIVITY DISORDER SYMPTOMS IN THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT STUDY (MOBA)

TH39. DOES TIME-OF-BLOOD DRAW IMPACT CELL-DERIVED DATA IN STUDIES OF SCHIZOPHRENIA?

29. EPIGENOME-WIDE ASSOCIATION META-ANALYSIS OF ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

SU5A RARE VARIANT ANALYSIS ON ATTENTION-DEFICIT HYPERACTIVITY DISORDER

INSIGHTS FROM >80 LOCI ASSOCIATED WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

6.71 ATTENTION IS PREDICTED BY ALZHEIMER’S DISEASE POLYGENIC RISK SCORE IN TYPICALLY DEVELOPING CHILDREN MORE THAN IN CHILDREN WITH ADHD

PARENT-OF-ORIGIN EFFECTS IN CHILDHOOD AGGRESSION

76 GENETIC ARCHITECTURE OF PERSISTENT ATTENTION DEFICIT/HYPERACTIVITY DISORDER

M2 THE ROLE OF LOW FREQUENCY VARIANTS ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND AUTISM SPECTRUM DISORDERS

W6. IMPACTS OF GENETICS AND PRENATAL DIET QUALITY ON ADHD SYMPTOMS ACROSS CHILDHOOD - A LONGITUDINAL STUDY IN THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT

Investigation of Shared Genetic Risk Between ADHD and Cardiometabolic Traits in a Norwegian Family Cohort Using Polygenic Transmission Disequilibrium Test

A CONTRIBUTION OF RARE COPY NUMBER VARIATIONS TO THE DEVELOPMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER: GENOME-WIDE META-ANALYSES IN 12548 INDIVIDUALS

F6GENETICS OF TREATMENT RESPONSE FOR ATOMOXETINE IN ADHD

SU6HYPERACTIVITY SYMPTOM IS PREDICTED BY AGE-OF-MENARCHE POLYGENIC RISK SCORE IN ADHD CHILDREN

Maternal Fiber Intake During Pregnancy and Development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father, and Child Cohort Study

Aktive Filter

Suchergebnisse filtern